Duration of Invasive Mechanical Ventilation Before Veno-Venous ExtraCorporeal Membrane Oxygenation for Covid-19 Related Acute Respiratory Distress Syndrome: The Experience of a Tertiary Care Center

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Jun 17

PMID 38882376

Authors

Charles Vidal

Mathilde Nativel

Berenice Puech

Florent Poirson

Radj Cally

Laurence Dangers

Eric Braunberger

Julien Jabot

Nicolas Allou

JeromeM Allyn

Affiliations

Soon will be listed here.

Abstract

Background: Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) is an efficient ventilatory support in patients with refractory Covid-19-related Acute Respiratory Distress Syndrome (ARDS), however the duration of invasive mechanical ventilation (IMV) before ECMO initiation as a contraindication is still controversial. The aim of this study was to investigate the impact of prolonged IMV prior to VV-ECMO in patients suffering from refractory Covid-19-related ARDS.

Methods: This single-center retrospective study included all patients treated with VV-ECMO for refractory Covid-19-related ARDS between January 1, 2020 and May 31, 2022. The impact of IMV duration was investigated by comparing patients on VV-ECMO during the 7 days (and 10 days) following IMV with those assisted after 7 days (and 10 days). The primary endpoint was in-hospital mortality.

Results: Sixty-four patients were hospitalized in the ICU for Covid-19-related refractory ARDS requiring VV-ECMO. Global in-hospital mortality was 55 %. Median duration of IMV was 4 [2; 8] days before VV-ECMO initiation. There was no significant difference in in-hospital mortality between patients assisted with IMV pre-VV-ECMO for a duration of ≤7 days (≤10 days) and those assisted after 7 days (and 10 days) (( = 0.59 and = 0.45).

Conclusion: This study suggests that patients assisted with VV-ECMO after prolonged IMV had the same prognosis than those assisted earlier in refractory Covid-19-related ARDS. Therefore, prolonged mechanical ventilation of more than 7-10 days should not contraindicate VV-ECMO support. An individual approach is necessary to balance the risks and benefits of ECMO in this population.

References

Lebreton G, Schmidt M, Ponnaiah M, Folliguet T, Para M, Guihaire J . Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study. Lancet Respir Med. 2021; 9(8):851-862. PMC: 8055207. DOI: 10.1016/S2213-2600(21)00096-5. View

Jounieaux V, Rodenstein D, Mahjoub Y . On Happy Hypoxia and on Sadly Ignored "Acute Vascular Distress Syndrome" in Patients with COVID-19. Am J Respir Crit Care Med. 2020; 202(11):1598-1599. PMC: 7706160. DOI: 10.1164/rccm.202006-2521LE. View

Grasselli G, Calfee C, Camporota L, Poole D, Amato M, Antonelli M . ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med. 2023; 49(7):727-759. PMC: 10354163. DOI: 10.1007/s00134-023-07050-7. View

Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L . COVID-19 pneumonia: different respiratory treatments for different phenotypes?. Intensive Care Med. 2020; 46(6):1099-1102. PMC: 7154064. DOI: 10.1007/s00134-020-06033-2. View

Le Pape S, Savart S, Arrive F, Frat J, Ragot S, Coudroy R . High-flow nasal cannula oxygen versus conventional oxygen therapy for acute respiratory failure due to COVID-19: a systematic review and meta-analysis. Ann Intensive Care. 2023; 13(1):114. PMC: 10667189. DOI: 10.1186/s13613-023-01208-8. View

Diaz R, Graf J, Zambrano J, Ruiz C, Espinoza J, Bravo S . Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study. Am J Respir Crit Care Med. 2021; 204(1):34-43. PMC: 8437120. DOI: 10.1164/rccm.202011-4166OC. View

Trahtemberg U, Slutsky A, Villar J . What have we learned ventilating COVID-19 patients?. Intensive Care Med. 2020; 46(12):2458-2460. PMC: 7549087. DOI: 10.1007/s00134-020-06275-0. View

Shekar K, Badulak J, Peek G, Boeken U, Dalton H, Arora L . Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. ASAIO J. 2020; 66(7):707-721. PMC: 7228451. DOI: 10.1097/MAT.0000000000001193. View

Hajage D, Combes A, Guervilly C, Lebreton G, Mercat A, Pavot A . Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis. Am J Respir Crit Care Med. 2022; 206(3):281-294. PMC: 9890253. DOI: 10.1164/rccm.202111-2495OC. View

10.

Schmidt M, Hajage D, Lebreton G, Monsel A, Voiriot G, Levy D . Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med. 2020; 8(11):1121-1131. PMC: 7426089. DOI: 10.1016/S2213-2600(20)30328-3. View

11.

Aries P, Huet O, Balicchi J, Mathais Q, Estagnasie C, Martin-Lecamp G . Characteristics and outcomes of SARS-COV 2 critically ill patients after emergence of the variant of concern 20H/501Y.V2: A comparative cohort study. Medicine (Baltimore). 2022; 101(39):e30816. PMC: 9524525. DOI: 10.1097/MD.0000000000030816. View

12.

Twohig K, Nyberg T, Zaidi A, Thelwall S, Sinnathamby M, Aliabadi S . Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis. 2021; 22(1):35-42. PMC: 8397301. DOI: 10.1016/S1473-3099(21)00475-8. View

13.

Rabie A, Elhazmi A, Azzam M, Abdelbary A, Labib A, Combes A . Expert consensus statement on venovenous extracorporeal membrane oxygenation ECMO for COVID-19 severe ARDS: an international Delphi study. Ann Intensive Care. 2023; 13(1):36. PMC: 10152433. DOI: 10.1186/s13613-023-01126-9. View

14.

Wilkinson D, Mercier A, Turpin M, Simbi M, Turpin J, Lebarbenchon C . Genomic evolution of SARS-CoV-2 in Reunion Island. Infect Genet Evol. 2022; 106:105381. PMC: 9598258. DOI: 10.1016/j.meegid.2022.105381. View

15.

Rello J, Belliato M, Dimopoulos M, Giamarellos-Bourboulis E, Jaksic V, Martin-Loeches I . Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium. Anaesth Crit Care Pain Med. 2020; 39(6):723-730. PMC: 7580531. DOI: 10.1016/j.accpm.2020.10.008. View

16.

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

17.

Lorusso R, De Piero M, Mariani S, Di Mauro M, Folliguet T, Taccone F . In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study. Lancet Respir Med. 2022; 11(2):151-162. PMC: 9671669. DOI: 10.1016/S2213-2600(22)00403-9. View

18.

Riera J, Alcantara S, Bonilla C, Fortuna P, Blandino Ortiz A, Vaz A . Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support. Eur Respir J. 2021; 59(2). PMC: 8620104. DOI: 10.1183/13993003.02463-2021. View

19.

Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C . Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med. 2018; 378(21):1965-1975. DOI: 10.1056/NEJMoa1800385. View

20.

Schmidt M, Hajage D, Landoll M, Pequignot B, Langouet E, Amalric M . Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study. Lancet Respir Med. 2023; 11(2):163-175. PMC: 9889098. DOI: 10.1016/S2213-2600(22)00438-6. View